Brief: Abivax Posts H1 Operating Loss Of EUR 93.7 Mln

Abivax SA

09/09/2025 05:56

Sept 9 (Reuters) - ABVX.PA:

SAID ON MONDAY H1 OPERATING LOSS OF EUR -93.7 MLN, VS EUR -80.0 MLN H1 2024

H1 R&D EXPENSES AT EUR -77.9 MLN, VS EUR -64.7 MLN H1 2024

H1 CASH POSITION OF EUR 60.9 MLN, VS EUR 144.2 MLN H1 2024

H1 TOTAL OPERATING INCOME OF EUR 2.1 MLN, VS EUR 6.8 MLN H1 2024

H1 TOTAL ASSETS OF EUR 119.6 MLN, VS EUR 205.2 MLN H1 2024

EXPECTS TO BE ABLE TO FUND ITS FORECASTED CASH FLOW REQUIREMENTS INTO THE FOURTH QUARTER OF 2027

 Source text for Workspace: https://tinyurl.com/29m6ahym
 Further company coverage: ABVX.PA

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))